ABBOTT LABORATORIES Annual Report, Year Ended Dec 31, 1998

Abbott Laboratories' 1998 10-K filing provides a snapshot of the company's financial position and operational activities as of December 30, 1998. While the provided text is largely navigational and descriptive of the SEC's website rather than the actual financial data of Abbott Laboratories, it indicates the filing date and period end. Investors would typically look to the detailed financial statements, management's discussion and analysis (MD&A), and risk factors sections within the full 10-K report for comprehensive insights. Without the specific financial figures and narrative from the report itself, a deep analysis is not possible. However, the existence of this filing signifies Abbott Laboratories' compliance with SEC reporting requirements. Key areas for investors to scrutinize in the actual report would include revenue trends across its business segments (e.g., pharmaceuticals, diagnostics, nutritionals, medical devices), profitability metrics, balance sheet strength, cash flow generation, and any forward-looking statements or identified risks that could impact future performance.